FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jennifer Quinn

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jennifer A Quinn; Sara Xiaoyin Jiang; David A Reardon; Annick Desjardins; James J Vredenburgh; Allan H Friedman; John H Sampson; Roger E McLendon; James E Herndon; Henry S Friedman
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
Jennifer A Quinn; Sara Xiaoyin Jiang; David A Reardon; Annick Desjardins; James J Vredenburgh; Jeremy Rich; Sridharan Gururangan; Allan H Friedman; Darell D Bigner; John H Sampson; Roger E McLendon; James E Herndon; Amy Walker; Henry S Friedman
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
Jennifer A Quinn; Sara Xiaoyin Jiang; David A Reardon; Annick Desjardins; James J Vredenburgh; Sridharan Gururangan; John H Sampson; Roger E McLendon; James E Herndon; Henry S Friedman
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jennifer Quinn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Jennifer A Quinn; Sara Xiaoyin Jiang; David A Reardon; Annick Desjardins; James J Vredenburgh; Allan H Friedman; John H Sampson; Roger E McLendon; James E Herndon; Henry S Friedman
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
Journal of neuro-oncology 2009;95(3):393-400.
2009: Jennifer A Quinn; Sara Xiaoyin Jiang; David A Reardon; Annick Desjardins; James J Vredenburgh; Jeremy Rich; Sridharan Gururangan; Allan H Friedman; Darell D Bigner; John H Sampson; Roger E McLendon; James E Herndon; Amy Walker; Henry S Friedman
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
Neuro-oncology 2009;11(5):556-61.
2009: Jennifer A Quinn; Sara Xiaoyin Jiang; David A Reardon; Annick Desjardins; James J Vredenburgh; Sridharan Gururangan; John H Sampson; Roger E McLendon; James E Herndon; Henry S Friedman
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
Cancer 2009;115(13):2964-70.
2008: Annick Desjardins; David A Reardon; James E Herndon; Jennifer Marcello; Jennifer A Quinn; Jeremy Rich; Sith Sathornsumetee; Sridharan Gururangan; John Sampson; Leighann Bailey; Darell D Bigner; Allan H Friedman; Henry S Friedman; James J Vredenburgh
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):7068-73.
2008: Sridharan Gururangan; Jeanne Krauser; Melody Watral; Tim Driscoll; Nicole Larrier; David A Reardon; Jeremy Rich; Jennifer A Quinn; James J Vredenburgh; Annick Desjardins; Roger E McLendon; Herbert Fuchs; Joanne Kurtzberg; Henry S Friedman
Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
Neuro-oncology 2008;10(5):745-51.
2008: Jill A Maxwell; Stewart P Johnson; Roger E McLendon; David W Lister; Krystle S Horne; Ahmed Rasheed; Jennifer A Quinn; Francis Ali-Osman; Allan H Friedman; Paul Modrich; Darell D Bigner; Henry S Friedman
Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4859-68.
2008: David A Reardon; Annick Desjardins; James J Vredenburgh; Sith Sathornsumetee; Jeremy Rich; Jennifer A Quinn; Theodore F Lagattuta; Merrill J Egorin; Sridharan Gururangan; Roger E McLendon; James E Herndon; Allan H Friedman; August J Salvado; Henry S Friedman
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
Neuro-oncology 2008;10(3):330-40.
2008: David A Reardon; Michael R Zalutsky; Gamal Akabani; R Edward Coleman; Allan H Friedman; James E Herndon; Roger E McLendon; Charles N Pegram; Jennifer A Quinn; Jeremy Rich; James J Vredenburgh; Annick Desjardins; Sridharan Guruangan; Susan Boulton; Renee H Raynor; Jeannette M Dowell; Terence Z Wong; Xiao-Guang Zhao; Henry S Friedman; Darell D Bigner
A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.
Neuro-oncology 2008;10(2):182-9.
2007: James J Vredenburgh; Annick Desjardins; James E Herndon; Jennifer Marcello; David A Reardon; Jennifer A Quinn; Jeremy Rich; Sith Sathornsumetee; Sridharan Gururangan; John Sampson; Melissa Wagner; Leighann Bailey; Darell D Bigner; Allan H Friedman; Henry S Friedman
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4722-9.
2007: Daniela A Bota; Annick Desjardins; Jennifer A Quinn; Mary Lou Affronti; Henry S Friedman
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.
Therapeutics and clinical risk management 2007;3(5):707-15.
2007: Sith Sathornsumetee; David A Reardon; Annick Desjardins; Jennifer A Quinn; James J Vredenburgh; Jeremy Rich
Molecularly targeted therapy for malignant glioma.
Cancer 2007;110(1):13-24.
2007: Annick Desjardins; Jennifer A Quinn; James J Vredenburgh; Sith Sathornsumetee; Allan H Friedman; James E Herndon; Roger E McLendon; James M Provenzale; Jeremy Rich; John H Sampson; Sridharan Gururangan; Jeannette M Dowell; August Salvado; Henry S Friedman; David A Reardon
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
Journal of neuro-oncology 2007;83(1):53-60.
2007: Sridharan Gururangan; Michael J Fisher; Jeffrey C Allen; James E Herndon; Jennifer A Quinn; David A Reardon; James J Vredenburgh; Annick Desjardins; Peter C Phillips; Melody Watral; Jeanne M Krauser; Allan H Friedman; Henry S Friedman
Temozolomide in children with progressive low-grade glioma.
Neuro-oncology 2007;9(2):161-8.
2007: James J Vredenburgh; Annick Desjardins; James E Herndon; Jeannette M Dowell; David A Reardon; Jennifer A Quinn; Jeremy Rich; Sith Sathornsumetee; Sridharan Gururangan; Melissa Wagner; Darell D Bigner; Allan H Friedman; Henry S Friedman
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1253-9.
2007: Michael A Badruddoja; Kara Penne; Annick Desjardins; David A Reardon; Jeremy Rich; Jennifer A Quinn; Sith Sathornsumetee; Allan H Friedman; Darell D Bigner; James E Herndon; Ann Cahill; Henry S Friedman; James J Vredenburgh
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme.
Neuro-oncology 2007;9(1):70-4.
2006: Jill A Maxwell; Stewart P Johnson; Jennifer A Quinn; Roger E McLendon; Francis Ali-Osman; Allan H Friedman; James E Herndon; Katja Bierau; Joseph Bigley; Darell D Bigner; Henry S Friedman
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma.
Molecular cancer therapeutics 2006;5(10):2531-9.
2006: David A Reardon; Jennifer A Quinn; Gamal Akabani; R Edward Coleman; Allan H Friedman; Henry S Friedman; James E Herndon; Roger E McLendon; Charles N Pegram; James M Provenzale; Jeannette M Dowell; Jeremy Rich; James J Vredenburgh; Annick Desjardins; John H Sampson; Sridharan Gururangan; Terence Z Wong; Michael A Badruddoja; Xiao-Guang Zhao; Darell D Bigner; Michael R Zalutsky
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):912-8.
2006: David A Reardon; Jennifer A Quinn; James J Vredenburgh; Sridharan Gururangan; Allan H Friedman; Annick Desjardins; Sith Sathornsumetee; James E Herndon; Jeannette M Dowell; Roger E McLendon; James M Provenzale; John H Sampson; Robert P Smith; Alan J Swaisland; Judith S Ochs; Peggy Lyons; Sandy Tourt-Uhlig; Darell D Bigner; Henry S Friedman; Jeremy Rich
Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):860-8.
2006: David A Reardon; Gamal Akabani; R Edward Coleman; Allan H Friedman; Henry S Friedman; James E Herndon; Roger E McLendon; Charles N Pegram; James M Provenzale; Jennifer A Quinn; Jeremy Rich; James J Vredenburgh; Annick Desjardins; Sridharan Gururangan; Sri Guruangan; Michael A Badruddoja; Jeannette M Dowell; Terence Z Wong; Xiao-Guang Zhao; Michael R Zalutsky; Darell D Bigner
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):115-22.
2005: David A Reardon; Merrill J Egorin; Jennifer A Quinn; Jeremy Rich; Jeremy N Rich; Sridharan Gururangan; Idharan Gururangan; James J Vredenburgh; Annick Desjardins; Sith Sathornsumetee; James M Provenzale; James E Herndon; Jeannette M Dowell; Michael A Badruddoja; Roger E McLendon; Theodore F Lagattuta; Kimberly P Kicielinski; Gregor Dresemann; John H Sampson; Allan H Friedman; August J Salvado; Henry S Friedman
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9359-68.
2005: Jennifer A Quinn; Annick Desjardins; Jon D Weingart; Henry Brem; M Eileen Dolan; Shannon M Delaney; James J Vredenburgh; Jeremy Rich; Allan H Friedman; David A Reardon; John H Sampson; Anthony E Pegg; Robert C Moschel; Robert Birch; Roger E McLendon; James M Provenzale; Sridharan Gururangan; Janet E Dancey; Jill Maxwell; Sandra Tourt-Uhlig; James E Herndon; Darell D Bigner; Henry S Friedman
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7178-87.
2005: David A Reardon; Jennifer A Quinn; Jeremy Rich; Annick Desjardins; James J Vredenburgh; Sridharan Gururangan; Sith Sathornsumetee; Michael A Badruddoja; Roger E McLendon; James M Provenzale; James E Herndon; Jeannette M Dowell; Jill L Burkart; Herbert B Newton; Allan H Friedman; Henry S Friedman
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Cancer 2005;104(7):1478-86.
2005: C Lynn Cheng; Stewart P Johnson; Stephen T Keir; Jennifer A Quinn; Francis Ali-Osman; Csaba Szabó; Hongshan Li; Andrew L Salzman; M Eileen Dolan; Paul Modrich; Darell D Bigner; Henry S Friedman
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
Molecular cancer therapeutics 2005;4(9):1364-8.
2005: David A Reardon; Jennifer A Quinn; James J Vredenburgh; Jeremy Rich; Sridharan Gururangan; Michael A Badruddoja; James E Herndon; Jeannette M Dowell; Allan H Friedman; Henry S Friedman
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
Cancer 2005;103(2):329-38.
2005: Annick Desjardins; Jeremy Rich; Jennifer A Quinn; James J Vredenburgh; Sridharan Gururangan; Sith Sathornsumetee; David A Reardon; Allan H Friedman; Darell D Bigner; Henry S Friedman
Chemotherapy and novel therapeutic approaches in malignant glioma.
Frontiers in bioscience : a journal and virtual library 2005;10():2645-68.
2004: Jennifer A Quinn; David A Reardon; Allan H Friedman; Jeremy Rich; John H Sampson; James J Vredenburgh; Sridharan Gururangan; James M Provenzale; Amy Walker; Holly Schweitzer; Darell D Bigner; Sandra Tourt-Uhlig; James E Herndon; Mary Lou Affronti; Susanne Jackson; Deborah Allen; Karen Ziegler; Cindy Bohlin; Christy Lentz; Henry S Friedman
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.
Neuro-oncology 2004;6(2):145-53.
2004: David A Reardon; Jennifer A Quinn; Jeremy Rich; Sridharan Gururangan; James J Vredenburgh; John H Sampson; James M Provenzale; Amy Walker; Michael A Badruddoja; Sandra Tourt-Uhlig; James E Herndon; Jeannette M Dowell; Mary Lou Affronti; Susanne Jackson; Deborah Allen; Karen Ziegler; Steven Silverman; Cindy Bohlin; Allan H Friedman; Darell D Bigner; Henry S Friedman
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.
Neuro-oncology 2004;6(2):134-44.
2004: Jeremy Rich; David A Reardon; Terry Peery; Jeannette M Dowell; Jennifer A Quinn; Kara Penne; Carol J Wikstrand; Lauren B Van Duyn; Janet E Dancey; Roger E McLendon; James C Kao; Timothy T Stenzel; B K Ahmed Rasheed; Sandra Tourt-Uhlig; James E Herndon; James J Vredenburgh; John H Sampson; Allan H Friedman; Darell D Bigner; Henry S Friedman
Phase II trial of gefitinib in recurrent glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):133-42.
2003: David N Korones; Michal Benita-Weiss; Thomas E Coyle; Laszlo Mechtler; Peter Bushunow; Brandon Evans; David A Reardon; Jennifer A Quinn; Henry Friedman
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Cancer 2003;97(8):1963-8.
2003: Jennifer A Quinn; David A Reardon; Allan H Friedman; Jeremy Rich; John H Sampson; James M Provenzale; Roger E McLendon; Sridharan Gururangan; Darell D Bigner; James E Herndon; Nicholas Avgeropoulos; Jonathan Lester Finlay; Sandra Tourt-Uhlig; Mary Lou Affronti; Brandon Evans; Valerie Stafford-Fox; Sara Zaknoen; Henry S Friedman
Phase II trial of temozolomide in patients with progressive low-grade glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(4):646-51.
2002: Jennifer A Quinn; James Pluda; M Eileen Dolan; Shannon M Delaney; Richard S. Kaplan; Jeremy Rich; Allan H Friedman; David A Reardon; John H Sampson; O Michael Colvin; Michael M Haglund; Anthony E Pegg; Robert C Moschel; Roger E McLendon; James M Provenzale; Sridharan Gururangan; Sandra Tourt-Uhlig; James E Herndon; Darell D Bigner; Henry S Friedman
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2277-83.
2002: David A Reardon; Gamal Akabani; R Edward Coleman; Allan H Friedman; Henry S Friedman; James E Herndon; Ilkcan Cokgor; Roger E McLendon; Charles N Pegram; James M Provenzale; Jennifer A Quinn; Jeremy Rich; Lorna V Regalado; John H Sampson; Timothy D Shafman; Carol J Wikstrand; Terence Z Wong; Xiao-Guang Zhao; Michael R Zalutsky; Darell D Bigner
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1389-97.
2001: Sridharan Gururangan; L Cokgor; Jeremy Rich; S Edwards; Mary Lou Affronti; Jennifer A Quinn; James E Herndon; James M Provenzale; Roger E McLendon; Sandra Tourt-Uhlig; John H Sampson; V Stafford-Fox; Sara Zaknoen; M Early; Allan H Friedman; Henry S Friedman
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.
Neuro-oncology 2001;3(4):246-50.
2000: Henry S Friedman; James Pluda; Jennifer A Quinn; Reginald Ewesuedo; L Long; Allan H Friedman; Ilkcan Cokgor; O Michael Colvin; Michael M Haglund; DM Ashley; Jeremy Rich; J Sampson; Anthony E Pegg; Robert C Moschel; Roger E McLendon; James M Provenzale; ES Stewart; Sandra Tourt-Uhlig; AM Garcia-Turner; James E Herndon; Darell D Bigner; M Eileen Dolan
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3522-8.